Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

Share Price is delayed by 15 minutes
Get Live Data
8.00    0.04 (0.51%)
Bid:
7.50
Ask:
8.50
Spread: 1.00 (13.333%)
Market Cap: £51.38m
KMK Live PriceLast checked at - London Stock Exchange

Intraday Kromek Share Chart

Director/PDMR Shareholding

20 Jul 2016 10:06

RNS Number : 7272E
Kromek Group PLC
20 July 2016
 

20 July 2016

 

Kromek Group plc

("Kromek" or the "Company")

 

Director/PDMR Shareholding

 

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has today received notification that Dr. Arnab Basu, Chief Executive Officer of the Company, today exercised options over 800,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to the EMI share option scheme.

 

Following the purchase, Dr. Basu has an interest in 2,872,000 Ordinary Shares representing 1.89% of the entire current issued share capital of the Company.

 

 

Enquiries

 

Kromek Group plc

Arnab Basu, CEO

Derek Bulmer, CFO

+44 (0)1740 626 060

Cenkos Securities plc

Bobbie Hilliam (NOMAD)

Julian Morse (Sales)

+44 (0)20 7397 8900

Luther Pendragon Ltd

Harry Chathli, Claire Norbury, Alexis Gore

+44 (0)20 7618 9100

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The information set out below is provided in accordance with the requirements of Article 19(3) of that Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Dr Arnab Basu

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Exercise of options over Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1.5p (exercise price)

 

800,000

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

800,000

 

 

1.5p (exercise price)

 

e)

 

Date of the transaction

 

 

20 July 2016

f)

 

Place of the transaction

 

 

N/a

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKKDKCBKKNOB
Date   Source Headline
4th Apr 20227:00 amRNSNew £1.7m CBRN contract
18th Jan 20227:00 amRNSInterim Results
17th Dec 20214:41 pmRNSSecond Price Monitoring Extn
17th Dec 20214:35 pmRNSPrice Monitoring Extension
14th Dec 20217:00 amRNSNotice of Results
26th Oct 20217:00 amRNSKromek awarded contract by US based OEM customer
29th Sep 20213:14 pmRNSHolding(s) in Company
27th Sep 20211:47 pmRNSDirector Share Purchase
23rd Sep 20217:00 amRNSNuclear security contract from US federal entity
8th Sep 202111:09 amRNSResult of AGM
13th Aug 20213:48 pmRNSNotice of AGM and Publication of Annual Report
3rd Aug 202112:25 pmRNSHolding(s) in Company
15th Jul 202111:05 amRNSSecond Price Monitoring Extn
15th Jul 202111:00 amRNSPrice Monitoring Extension
14th Jul 20217:00 amRNSFinal Results
14th Jul 20217:00 amRNSNew Contracts
1st Jul 20217:00 amRNSNotice of Results
24th Jun 20214:41 pmRNSSecond Price Monitoring Extn
24th Jun 20214:36 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSKromek awarded new DARPA bio-threat contract
12th May 20212:50 pmRNSDirector Share Purchase
11th May 20217:00 amRNSBusiness and Trading Update
21st Apr 20214:32 pmRNSHolding(s) in Company
9th Mar 20217:00 amRNSKromek awarded Nuclear Detection contract
4th Mar 20211:32 pmRNSHolding(s) in Company
2nd Mar 20218:30 amRNSPDMR Dealings
1st Mar 20212:53 pmRNSResults of Placing, Open Offer and General Meeting
1st Mar 20217:00 amRNSNew Medical Screening and Nuclear Security orders
19th Feb 20212:05 pmRNSSecond Price Monitoring Extn
19th Feb 20212:01 pmRNSPrice Monitoring Extension
15th Feb 20217:00 amRNSPosting of Circular
12th Feb 202111:05 amRNSSecond Price Monitoring Extn
12th Feb 202111:00 amRNSPrice Monitoring Extension
12th Feb 202110:30 amRNSPlacing and Open Offer to raise up to £13 million
4th Feb 20212:00 pmRNSIssue of Equity and Total Voting Rights
26th Jan 20215:15 pmRNSHolding(s) in Company
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20212:05 pmRNSSecond Price Monitoring Extn
22nd Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
14th Jan 20219:35 amRNSHolding(s) in Company
13th Jan 20217:01 amRNSFunding to advance Bio-Threat Detection solution
13th Jan 20217:00 amRNSInterim Results
7th Jan 202111:05 amRNSSecond Price Monitoring Extn
7th Jan 202111:01 amRNSPrice Monitoring Extension
16th Dec 20207:00 amRNSDirectorate Changes
14th Dec 202012:45 pmRNSHolding(s) in Company
8th Dec 20207:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.